Treatment of severe myasthenia gravis with large doses of ACTH.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy*; D011189:Potassium Chloride / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D013148:Spironolactone; D011189:Potassium Chloride; D000324:Adrenocorticotropic Hormone